Tag: Cinacalcet

Although parathyroidectomy is a curative treatment for many cases of hyperparathyroidism, achieving high success rates, a subset of patients may experience persistent or recurrent disease. In these specific cases, doctors may prescribe **cinacalcet after parathyroidectomy** to manage ongoing high calcium and parathyroid hormone levels.

A study published in the *New England Journal of Medicine* showed cinacalcet treatment significantly reduced serum phosphorus levels in dialysis patients with secondary hyperparathyroidism. However, the answer to **does cinacalcet affect phosphorus** isn't a simple yes or no; its impact depends on the patient's specific condition and overall mineral regulation.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, parathyroid diseases affect the body's vital calcium regulation. Deciding **what drug is used to treat parathyroid disease** depends entirely on whether the glands are overactive (hyperparathyroidism) or underactive (hypoparathyroidism).

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), with a global prevalence estimated at 49.5%. To manage this and related conditions, a key question for patients and providers is, **what is Cinacalcet?** It's a vital medication for controlling hormone levels.

According to a 2013 meta-analysis, Cinacalcet significantly reduces the need for parathyroidectomy in patients with chronic kidney disease on dialysis. A calcimimetic drug, Cinacalcet tablets are primarily used to manage specific conditions involving overactive parathyroid glands and high calcium levels in the blood. This medication works by increasing the sensitivity of the body's calcium-sensing receptors, which in turn lowers parathyroid hormone (PTH) and calcium levels.